Belden, Inc. (BDC) Tops Q1 EPS by 1c, Posts Q2 Guidance & Raises FY11
Tweet
Share
E-mailGet Alerts BDC Hot Sheet
Price: $110.92 -0.91%
EPS Growth %: +14.7%
Financial Fact:
Continuing operations: 0.69
Today's EPS Names:
VIVO, OCCI, ALZN, More
EPS Growth %: +14.7%
Financial Fact:
Continuing operations: 0.69
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Belden, Inc. (NYSE: BDC) reported Q1 EPS of $0.46, $0.01 better than the analyst estimate of $0.45. Revenue for the quarter came in at $461.6 million versus the consensus estimate of $449.95 million.
Belden, Inc. sees Q2 2011 EPS of $0.58-$0.61, versus the consensus of $0.59. Belden, Inc. sees Q2 2011 revenue of $510-$515 million, versus the consensus of $478.74 million.
Belden, Inc. sees FY2011 EPS of $2.15-$2.30, versus the consensus of $2.24. Belden, Inc. sees FY2011 revenue of $1.96-$2 billion, versus the consensus of $1.89 billion.
Belden, Inc. sees Q2 2011 EPS of $0.58-$0.61, versus the consensus of $0.59. Belden, Inc. sees Q2 2011 revenue of $510-$515 million, versus the consensus of $478.74 million.
Belden, Inc. sees FY2011 EPS of $2.15-$2.30, versus the consensus of $2.24. Belden, Inc. sees FY2011 revenue of $1.96-$2 billion, versus the consensus of $1.89 billion.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lennar Corp. (LEN) Misses Q3 EPS by 10c
- Forgent Power Solutions, Inc. (FPS) Tops Q2 EPS by 1c, Beats on Revenue; Offers FY27 Guidance
- Kestra Medical Technologies, Ltd. (KMTS) Reports Q1 Loss of $0.75/sh
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
